Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3846233 | Advances in Chronic Kidney Disease | 2015 | 8 Pages |
Abstract
Atherosclerotic renal artery stenosis (ARAS) remains a major cause of secondary hypertension and kidney failure. Randomized prospective trials show that medical treatment should constitute the main therapeutic approach in ARAS. Regardless of intensive treatment and adequate blood pressure control, however, renal and extrarenal complications are not uncommon. Yet, the precise mechanisms, accurate detection, and optimal treatment in ARAS remain elusive. Strategies oriented to early detection and targeting these pathogenic pathways might prevent development of clinical end points. Here, we review the results of recent clinical trials, current understanding of the pathogenic mechanisms, novel imaging techniques to assess kidney damage in ARAS, and treatment options.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Soon Hyo Kwon, Lilach O. Lerman,